Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Heart failure associated with chronic Chagas cardiomyopathy increases the risk of impaired lung function and reduced submaximal functional capacity.

Autor: da Silva PB; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Diniz CP; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Mediano MFF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil; Department of Research and Education, National Institute of Cardiology, Rio de Janeiro, RJ, Brazil., Mendes FSNS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Reis LFF; Postgraduate Program in Rehabilitation Sciences, Augusto Motta University Center, Rio de Janeiro, RJ, Brazil., Reis MS; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Saraiva RM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., de Holanda MT; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Mazzoli-Rocha F; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. Electronic address: flavia.mazzoli@ini.fiocruz.br., de Sousa AS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Publikováno v: Heart & lung : the journal of critical care [Heart Lung] 2025 Jan-Feb; Vol. 69, pp. 222-228. Date of Electronic Publication: 2024 Nov 05.

A guide for the generation of repositories of clinical samples for research on Chagas disease.

Autor: Martínez-Peinado N; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; Secció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain., Gabaldón-Figueira JC; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain., Rodrigues Ferreira R; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (LITEB-IOC/Fiocruz), Rio de Janeiro, Brazil.; Laboratory of Applied Genomics and Bioinnovations, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, (LAGABI-IOC/Fiocruz), Rio de Janeiro, Brazil., Carmen Thomas M; Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), PTS-Granada, Granada, Spain., López MC; Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), PTS-Granada, Granada, Spain., Cremonini Araújo-Jorge T; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (LITEB-IOC/Fiocruz), Rio de Janeiro, Brazil., Alarcón de Noya B; Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela., Berón S; Fundación Mundo Sano, Buenos Aires, Argentina., Ramsey J; Centro Regional de Investigación en Salud Pública (CRISP), Instituto Nacional de Salud Pública (INSP), Tapachula, Chiapas, México., Losada Galván I; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain., Schijman AG; Laboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular 'Dr. Héctor N. Torres' - INGEBI-CONICET, Buenos Aires, Argentina., González Martínez A; Departamento de Investigación, Salvando Latidos A.C., Guadalajara, Mexico.; Departamento de Investigación, Instituto Cardiovascular de Mínima Invasión (ICMI), Guadalajara, Mexico., Mariano Ruiz A; Instituto Nacional de Parasitología 'Dr Mario Fatala Chaben' ANLIS MALBRÁN, Ministerio de Salud, Buenos Aires, Argentina.; CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina., Rojas G; Universidad Mayor de San Simón and Fundación CEADES, Cochabamba, Bolivia., Magalhães Saraiva R; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brasil., Noya-González O; Instituto de Medicina Tropical, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.; Cátedra de Parasitología, Escuela ¨Luís Razetti' Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.; Centro para Estudios Sobre Malaria, Instituto de Altos Estudios 'Dr. Arnoldo Gabaldón', Ministerio del Poder Popular para la Salud (MPPS), Caracas, Venezuela., Gómez A; Fundación Mundo Sano, Buenos Aires, Argentina., Maldonado RA; Department of Biological Sciences, The University of Texas at El Paso, El Paso, Texas, United States of America., Pinto J; Universidad Mayor de San Simón and Fundación CEADES, Cochabamba, Bolivia., Torrico F; Universidad Mayor de San Simón and Fundación CEADES, Cochabamba, Bolivia., Scandale I; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland., Agüero F; Instituto de Investigaciones Biotecnológicas (IIB)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Martín, Buenos Aires, Argentina.; Escuela de Bio y Nanotecnologías (EByN), Universidad de San Martín (UNSAM), San Martín, Buenos Aires, Argentina., Pinazo MJ; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain., Gascón J; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brasil., Alonso-Padilla J; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic - University of Barcelona, Barcelona, Spain.; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Aug 15; Vol. 18 (8), pp. e0012166. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024).

Physical activity levels during COVID-19 pandemic and its associated factors in patients with Chagas disease.

Autor: Xavier IGG; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Andrade PM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Vitor RL; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Barros TC; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Portela LF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., de Holanda MT; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sangenis LHC; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sperandio da Silva GM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mazzoli-Rocha F; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mendes FSNS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., da Costa AR; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Quintana MSB; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Araujo IL; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Junqueira ACV; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pinheiro RO; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Georg I; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Paravidino VB; Department of Epidemiology, Institute of Social Medicine Hésio Cordeiro, State University of Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Physical Education and Sports, Naval Academy, Brazilian Navy, Rio de Janeiro, Brazil., Gonçalves TR; Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Saraiva RM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mediano MFF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Department of Research and Education, National Institute of Cardiology, Rio de Janeiro, Brazil.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Aug 06; Vol. 11, pp. 1411977. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).

Why Treat Chronic Forms of Chagas Disease with Benznidazole if Adverse Reactions are Very Frequent?

Autor: Hasslocher-Moreno AM; Fundação Oswaldo Cruz - Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ - Brasil.

Publikováno v: Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2024 Aug; Vol. 121 (8), pp. e20240426.